Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes
暂无分享,去创建一个
M. Woodward | G. Mancia | B. Williams | A. Rodgers | M. Marre | J. Chalmers | B. Neal | S. Zoungas | S. Harrap | L. Lisheng | Y. Hirakawa | K. Mohammedi | Lisheng Liu
[1] F. Fiordaliso,et al. Prospective study on microangiopathy in type 2 diabetic foot ulcer , 2016, Diabetologia.
[2] T. Byers. Excess Mortality among Persons with Type 2 Diabetes. , 2016, The New England journal of medicine.
[3] A. Rosengren,et al. Excess Mortality among Persons with Type 2 Diabetes. , 2015, The New England journal of medicine.
[4] Mark Woodward,et al. Usual blood pressure, peripheral arterial disease, and vascular risk: cohort study of 4.2 million adults , 2015, BMJ : British Medical Journal.
[5] T. Wong,et al. Relationship of systemic endothelial function and peripheral arterial stiffness with diabetic retinopathy , 2014, British Journal of Ophthalmology.
[6] C. Sum,et al. High normal albuminuria is independently associated with aortic stiffness in patients with Type 2 diabetes , 2014, Diabetic medicine : a journal of the British Diabetic Association.
[7] Manesh R Patel,et al. Association of the ankle-brachial index with history of myocardial infarction and stroke. , 2014, American heart journal.
[8] V. Aboyans,et al. Risk Factors for Incident Peripheral Arterial Disease in Type 2 Diabetes: Results From the Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes (BARI 2D) Trial , 2014, Diabetes Care.
[9] Igor Rudan,et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis , 2013, The Lancet.
[10] M. Dorgan,et al. Paradoxically lower prevalence of peripheral arterial disease in South Asians: a systematic review and meta-analysis , 2013, Heart.
[11] Mark Woodward,et al. Effects of the Endpoint Adjudication Process on the Results of a Randomised Controlled Trial: The ADVANCE Trial , 2013, PloS one.
[12] J. Tardif,et al. Ankle-brachial index and cardiovascular outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial. , 2012, American heart journal.
[13] N. Cook,et al. High-Molecular-Weight and Total Adiponectin Levels and Incident Symptomatic Peripheral Artery Disease in Women: A Prospective Investigation , 2011, Circulation.
[14] Y. Iwamoto,et al. Arterial Stiffness Is Associated With Incident Albuminuria and Decreased Glomerular Filtration Rate in Type 2 Diabetic Patients , 2011, Diabetes Care.
[15] J. Gross,et al. Diabetic Retinopathy Predicts All-Cause Mortality and Cardiovascular Events in Both Type 1 and 2 Diabetes , 2011, Diabetes Care.
[16] R. Roussel,et al. Use and utility of ankle brachial index in patients with diabetes. , 2011, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[17] G. Salles,et al. Microvascular degenerative complications are associated with increased aortic stiffness in type 2 diabetic patients. , 2009, Atherosclerosis.
[18] Maria Mori Brooks,et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. , 2009, The New England journal of medicine.
[19] S. Schinner. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes , 2009 .
[20] A Hofman,et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. , 2008, JAMA.
[21] T. Wong,et al. Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type2 diabetic patients , 2008 .
[22] Diederick Grobbee,et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. , 2008, The New England journal of medicine.
[23] N. Cook,et al. Symptomatic Peripheral Arterial Disease in Women: Nontraditional Biomarkers of Elevated Risk , 2008, Circulation.
[24] Anushka Patel,et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial , 2007, The Lancet.
[25] Ronald Klein,et al. Is Diabetic Retinopathy an Independent Risk Factor For Ischemic Stroke? , 2007, Stroke.
[26] H. Parving,et al. Microalbuminuria as an early marker for cardiovascular disease. , 2006, Journal of the American Society of Nephrology : JASN.
[27] B. Gersh,et al. Rationale for the revascularization arm of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. , 2006, The American journal of cardiology.
[28] P. Norman,et al. Peripheral arterial disease and risk of cardiac death in type 2 diabetes: the Fremantle Diabetes Study. , 2006, Diabetes Care.
[29] G. Lowe,et al. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study. , 2006, American journal of epidemiology.
[30] L. De Angelis,et al. Aortic pulse wave velocity and albuminuria in patients with type 2 diabetes. , 2005, Journal of the American Society of Nephrology : JASN.
[31] Elizabeth Selvin,et al. Prevalence of and Risk Factors for Peripheral Arterial Disease in the United States: Results From the National Health and Nutrition Examination Survey, 1999–2000 , 2004, Circulation.
[32] V. Mohan,et al. Association of carotid intima-media thickness and arterial stiffness with diabetic retinopathy: the Chennai Urban Rural Epidemiology Study (CURES-2). , 2004, Diabetes care.
[33] Henrik Vestergaard,et al. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. , 2004, Archives of internal medicine.
[34] S. Fukumoto,et al. Arterial wall stiffness is associated with peripheral circulation in patients with type 2 diabetes. , 2003, Atherosclerosis.
[35] S. Kanters,et al. Angiographic distribution of lower extremity atherosclerosis in patients with and without diabetes , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[36] R. Holman,et al. UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. , 2002, Diabetes care.
[37] S. Morikawa,et al. Increased arterial wall stiffness limits flow volume in the lower extremities in type 2 diabetic patients. , 2001, Diabetes care.
[38] R. Collins,et al. Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation , 2001 .
[39] T. Shoji,et al. Femoral artery wall thickness and stiffness in evaluation of peripheral vascular disease in type 2 diabetes mellitus. , 2001, Atherosclerosis.
[40] A. Boulton,et al. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. , 2001, Diabetes care.
[41] A. Dart,et al. Pulse pressure--a review of mechanisms and clinical relevance. , 2001, Journal of the American College of Cardiology.
[42] Advance Management Committee. Study Rationale and Design of ADVANCE: Action in Diabetes and Vascular disease – preterax and diamicron MR controlled evaluation , 2001, Diabetologia.
[43] P. Challande,et al. Fibronectin expression and aortic wall elastic modulus in spontaneously hypertensive rats. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[44] M. Laakso,et al. Retinopathy Predicts Coronary Heart Disease Events in NIDDM Patients , 1996, Diabetes Care.
[45] R. D. Latham,et al. Regional wave travel and reflections along the human aorta: a study with six simultaneous micromanometric pressures. , 1985, Circulation.